WO2001057241A2 - Cast analyte diffusion-limiting membranes using photopolymerizable hydrophylic monomers - Google Patents

Cast analyte diffusion-limiting membranes using photopolymerizable hydrophylic monomers Download PDF

Info

Publication number
WO2001057241A2
WO2001057241A2 PCT/US2001/003304 US0103304W WO0157241A2 WO 2001057241 A2 WO2001057241 A2 WO 2001057241A2 US 0103304 W US0103304 W US 0103304W WO 0157241 A2 WO0157241 A2 WO 0157241A2
Authority
WO
WIPO (PCT)
Prior art keywords
layer
membrane system
water
analyte
diffusion
Prior art date
Application number
PCT/US2001/003304
Other languages
French (fr)
Other versions
WO2001057241A3 (en
Inventor
Patrick Kelly
Jarad Schiffer
Original Assignee
Spectrx, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectrx, Inc. filed Critical Spectrx, Inc.
Priority to EP01908778A priority Critical patent/EP1252509A2/en
Priority to JP2001555864A priority patent/JP2003521248A/en
Priority to CA002398810A priority patent/CA2398810A1/en
Priority to MXPA02007447A priority patent/MXPA02007447A/en
Priority to BR0108042-3A priority patent/BR0108042A/en
Priority to AU36612/01A priority patent/AU3661201A/en
Publication of WO2001057241A2 publication Critical patent/WO2001057241A2/en
Publication of WO2001057241A3 publication Critical patent/WO2001057241A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C12Q1/002—Electrode membranes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
    • C12Q1/006—Enzyme electrodes involving specific analytes or enzymes for glucose

Definitions

  • the present invention relates in general to a diffusion-limiting hydrogel membrane system for use in analyte detection systems. More specifically, the present invention relates to cast analyte diffusion-limiting hydrogel membranes for filtering an analyte from fluids, comprising a water soluble photopolymerizable hydrophilic hydrogel monomer, capable of limiting the amount of analyte that will react with an analyte responsive enzyme and thus, further enabling a detection device to operate on a discrete basis or continually over an extended period of time.
  • the present invention provides a diffusion-limiting hydrogel membrane system for filtering analytes or other desired characteristics from a fluid.
  • the hydrogel membrane system can be employed in a detection device wherein the diffusion-limiting hydrogel membrane operates to regulate the amount of analyte that is present at the sensor electrodes at any given time, thus, allowing the sensor electrodes to operate on a discrete basis or continuously over longer periods of time without substantially depleting the amount of reactant present on the sensor electrodes.
  • Figure 1A illustrates a cross sectional view of an assay device containing one embodiment of a cast analyte diffusion limiting membrane according to the present invention.
  • Figure IB illustrates a front view of an assay device containing one embodiment of a cast analyte diffusion limiting membrane according to the present invention.
  • Figure 2 is a graph indicating the results of example 1.
  • Figure 3 is a graph indicating the results of example 2.
  • Ranges may be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, another embodiment comprises from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent "about,” it will be understood that the particular value forms another embodiment.
  • analyte shall mean the component that is being filtered from a liquid or gas and/or detected and/or measured in a detection device.
  • the analyte can include without limitation, glucose, acetoacetate, ammonia, catecholamines, creatine, creatinine, fructose, galactose, ⁇ -hydroxybutyric acid, bilirubin, lactate, lactic acid, amino acids, urea, uric acid, salicylates, pH, magnesium, calcium, lithium, lead, potassium, sodium, chloride, iron, and any other electrolyte, vitamin, protein, nutrient, pharmaceutical compounds, or other such characteristic desired.
  • electrolyte means a chemical compound that ionizes when dissolved to produce an electrically conductive medium.
  • fluid means a liquid or a gas.
  • biological fluid means blood serum, whole blood, interstitial fluid, lymph fluid, spinal fluid, plasma or any combinations of these fluids. "Interstitial fluid” further refers to the clear fluid that occupies the space between the cells in the body.
  • biological membrane means the outer layer of an organism, such as skin or mucous membrane, the structure separating one area of an organism from another, such as a capillary wall, or the outer layer of an organism which separates the organism from its external environment, such as skin, buccal mucosa or other mucous membrane.
  • hydrogel means a polymeric material that can absorb 20% or more of its weight in water while simultaneously maintaining a distinct three- dimensional structure. More specifically, the hydrogels according to the present invention can be comprised of an aerogel that dries without significant collapse of the macroscopic structure and which absorbs water into macropores without substantial macroscopic swelling or, alternatively, xerogels which absorb water by swelling. It is further envisioned by the present invention that suitable hydrogels can include dry polymers that will swell in aqueous environments.
  • suitable hydrogels for use in the present invention include without limitation 2-hydroxyethyl methacrylate, N,N,-dimethacrylamide, N-vinylpyrrolidine, polyethyleneglycol dimethacrylate, and/or copolymers thereof.
  • the term "cast” means a method of forming a coating over an electrode area. Representative examples can include doctor blading, spraying, and/or dipping.
  • diffusion-limiting hydrogel membrane means a hydrogel that limits the flow of analytes from one space to another.
  • the term “detection device” means any assay device suitable for measuring a desired characteristic of a fluid on a continual or discrete basis.
  • An example of such device is that disclosed by International Patent Application No. PCT/US00/09393 which application is incorporated herein by this reference in its entirety.
  • the term “sensor electrode” means an electrode suitable for detecting the concentration of various ions in an aqueous and/or gaseous environment. Examples of suitable sensor electrodes according to the present invention include without limitation platinumized carbon ink or platinum metal held at a given electrical potential to cause the reduction of an analyte.
  • the present invention shows a cross-sectional view of a detection device 10 which operates on a continuous basis.
  • the device 10 contains an inlet port 40 to receive fluid and a chamber 50 in fluid communication with the inlet port 40, and an outlet port 60 in fluid communication with the chamber 50, where the outlet port 60 is designed to allow the discharge of fluid.
  • the chamber 50 further comprises a first working sensor electrode 12, a second working sensor electrode 14, a reference electrode 16 and a counter electrode 18.
  • a first layer of an analyte responsive enzyme 20, such as glucose oxidase, is applied to at least one of the working sensor electrodes 12 or 14.
  • a second layer comprising a composition comprising a diffusion-limiting hydrogel membrane 30 is applied to at least one of the working sensor electrodes 12 or 14, wherein the first layer is in direct contact with at least one sensor electrode and the second layer is in direct contact with the first layer.
  • the device 10 of the present invention may further comprise an external channel 70, wherein one end of the external channel 70 is in fluid communication with the inlet port 40 and the other end is in fluid communication with at least one liquid and/or gas.
  • the analyte responsive enzyme 20 and the composition comprising a diffusion-limiting hydrogel membrane are mixed together and applied to at least one of the working sensor electrodes 12 or 14 as a mono-layer membrane system.
  • Figure IB is a front view of the detection device 10 and is described the same as figure 1 A above.
  • the present invention provides a diffusion limiting membrane system for filtering an analyte from a liquid, comprising: a) a first layer comprising an analyte responsive enzyme; and b) a second layer comprising a water-soluble monomer composition, wherein the first layer is in direct contact with one or more sensor electrodes and the second layer is in direct contact with the first layer.
  • a diffusion-limiting hydrogel membrane system for filtering glucose from fluids comprising a glucose limiting membrane comprising a composition comprising a water soluble monomer, an enzyme, and an initiator, wherein the composition is disposed on one or more sensor electrodes and cured in the presence of sunlight or UV light.
  • the present invention further provides a diffusion-limiting hydrogel membrane system for filtering glucose from fluids comprising a composition comprising a water soluble monomer, a cross-linking agent, an enzyme, and an initiator, wherein the composition is disposed on one or more sensor electrodes and cured in the presence of sunlight or UV light.
  • the present invention further provides a diffusion-limiting hydrogel membrane system comprising: a) a first layer comprising an analyte responsive enzyme; and b) a second layer comprising a water-soluble monomer composition, wherein the first layer is in direct contact with one or more sensor electrodes and the second layer is in direct contact with the first layer.
  • the present invention provides a diffusion-limiting hydrogel membrane for filtering an analyte from a fluid, comprising: a) a first layer comprising an analyte responsive enzyme; and b) a second layer comprising a water-soluble monomer composition, wherein the first layer is in direct contact with one or more sensor electrodes and the second layer is in direct contact with the first layer.
  • Suitable analytes for use with the present invention include without limitation glucose, acetoacetate, ammonia, catecholamines, creatine, creatinine, fructose, galactose, ⁇ -hydroxybutyric acid, bilirubin, lactate, lactic acid, amino acids, urea, uric acid, salicylates, pH, magnesium, calcium, lithium, lead, potassium, sodium, chloride, iron, and any other electrolyte, vitamin, protein, nutrient, pharmaceutical compounds, or other such characteristic desired.
  • Suitable analyte responsive enzymes for use in the diffusion-limiting hydrogel membranes of the present invention will be dependent upon the desired use of the invention.
  • the glucose responsive enzyme is glucose oxidase, which is available from Sigma.
  • any appropriate enzyme recognized for use in detecting glucose could be employed.
  • the analyte responsive enzyme is dissolved in deionized water or phosphate buffered de-ionized water.
  • the phosphate buffer system acts to maintain the analyte responsive enzyme at a pH value within the range of normal physiological levels.
  • the analyte responsive enzyme can be dissolved in an amount of from about Img/mL to about lOOmg/mL.
  • the enzyme is dissolved in an amount of from about Img/mL to about 50mg/mL.
  • the enzyme can be dissolved in an amount of from about Img/mL to about lOmg/mL.
  • Suitable water soluble monomers for use in the present include 2-hydroxyethyl methacrylate, N,N,-dimethacrylamide, N-vinylpyrrolidine, polyethyleneglycol dimethacrylate, and/or copolymers thereof.
  • the water- soluble monomers for use in the inventive membranes are highly water permeable hydrogels, such as 2-hydroxyethyl methacrylate (HEMA).
  • HEMA 2-hydroxyethyl methacrylate
  • the water soluble monomer of the present invention is diluted in an aqueous medium.
  • the hydrogel monomers of the present invention can be diluted in the aqueous medium at a range of dilution from about 0.01% to about 50% by volume.
  • the range of dilution is from about 0.05% to about 10% by volume.
  • the range of dilution is from about 0.1% to about 5% by volume.
  • the water soluble monomer of the present invention can further comprise one or more initiators.
  • Any water soluble UV or thermal initiators known in the art can be used with the present invention.
  • suitable initiators for use in the invention include 2,2 dimethoxy-2- phenylacetophenone, Vazo 52®, available from DuPont, and Vazo 64®, also available from DuPont.
  • the initiator is introduced into the water soluble monomer in an amount of from about 1 to about 10% by weight. In another embodiment, the initiator is introduced into the water soluble monomer in an amount of from about 2 to about 5% by weight.
  • the water soluble monomer of the present invention can be cast or cured directly onto an electrode in the presence of sunlight or ultraviolet light without requiring the use of an adhesive or special processing to further protect an enzyme within the system.
  • the water soluble monomer composition further comprises water soluble cross-linking agents.
  • the cross-linking agent can participate in the polymerization of the water soluble monomer and thus facilitate the formation of the desired hydrogel membrane.
  • suitable cross- linking agents include without limitation polytheyleneglycol dimethacryalate and/or gluteraldehyde.
  • any water soluble free radical cross-linking agents can be used in the present invention.
  • the cross-linking agents can be introduced into the water soluble monomer in an amount of from about 1 to about 10% by volume.
  • the cross-linking agent can be introduced into the water soluble monomer in an amount of from about 2 to about 5% by volume.
  • the thickness of the membranes of the present invention is from about 2 to about 50 micrometers. In another embodiment, the thickness of the membrane is from about 2 to about 25 micrometers. In still a further embodiment, the thickness of the membrane is from about 2 to about 20 micrometers.
  • Example 1 relates to a bi-layer diffusion-limiting hydrogel membrane system for filtering glucose from biological fluids.
  • solution 1 was prepared, and consisted of 1000 ⁇ l of 2-hydroxyethyl methacrylate and 4% by weight of a UV initiator, 2,2 Dimethoxy-2-phenylacetophenone .
  • a detection device 10 such as the one shown in figure 1 A, a 0.5 ⁇ l drop of solution 2, comprised of 495 ⁇ l of a phosphate buffer system (PBS), lO ⁇ l of gluteraldehyde, 4 mg of Glucose Oxidase, and 30 mg of bovine serum albumin (BSA), was placed on at least one of the working sensor electrodes 12 or 14.
  • PBS phosphate buffer system
  • BSA bovine serum albumin
  • This drop was allowed to dry for 12hrs after which a l ⁇ l drop of solution 3, which contained 495 ⁇ l of PBS and lO ⁇ l of solution 1, was placed on top of the drop on the at least one working sensor electrode 12 or 14.
  • This second drop was exposed to long wave U V radiation for 0.5 hrs, wherein the radiation value was approximately 415nm tc approximately 430nm.
  • the cured hydrogel membrane was then placed in a solution of de-ionized water and PBS and tested against a series of glucose levels as seen in figure 2.
  • the results for this bi-layer hydrogel membrane system are set forth in said figure 2, wherein it illustrates that the bi-layer diffusion limiting hydrogel membrane system of example 1 was suitable for accurately detecting glucose levels at concentrations of up to approximately 25 to 30mM.
  • Example 2 relates to a single layer diffusion-limiting hydrogel membrane system for filtering glucose from biological fluids.
  • solution 1 was prepared, and consisted of 1000 ⁇ l of 2-hydroxyethyl methacrylate and 4% by weight of 2,2 Dimethoxy-2-phenylacetophenone.
  • a detection device 10 such as the one shown in figure 1A
  • a 0.5 ⁇ l drop of solution 2 which contained 495 ⁇ l of PBS, 4 mg of Glucose Oxidase, and 10 ⁇ l of solution 1
  • This 0.5 ⁇ l drop was exposed to long wave UV radiation for 0.5 hrs, wherein the radiation value was approximately 415nm to approximately 430nm.

Abstract

The present ivention provides a diffusion limiting membrane system for filtering an analyte from a fluid, comprising: a) a first layer comprising an analyte responsive enzyme; and b) a second layer comprising a water-soluble monomer composition, wherein the first layer is in direct contact with one or more sensor electrodes and the second layer is in direct contact with the first layer.

Description

CAST ANALYTE DIFFUSION-LIMITING MEMBRANES USING PHOTOPOLYMERIZABLE HYDROPHYLIC MONOMERS
CROSS REFERENCE TO RELATED APPLICATIONS
This application claims priority to U.S. Provisional Application Serial No.
60/179,716, filed February 1, 2000, which application is incorporated herein by this reference in its entirety.
FIELD OF INVENTION
The present invention relates in general to a diffusion-limiting hydrogel membrane system for use in analyte detection systems. More specifically, the present invention relates to cast analyte diffusion-limiting hydrogel membranes for filtering an analyte from fluids, comprising a water soluble photopolymerizable hydrophilic hydrogel monomer, capable of limiting the amount of analyte that will react with an analyte responsive enzyme and thus, further enabling a detection device to operate on a discrete basis or continually over an extended period of time.
SUMMARY OF THE INVENTION
The present invention provides a diffusion-limiting hydrogel membrane system for filtering analytes or other desired characteristics from a fluid. The hydrogel membrane system can be employed in a detection device wherein the diffusion-limiting hydrogel membrane operates to regulate the amount of analyte that is present at the sensor electrodes at any given time, thus, allowing the sensor electrodes to operate on a discrete basis or continuously over longer periods of time without substantially depleting the amount of reactant present on the sensor electrodes.
Additional advantages of the invention will be obvious from the description, or may be learned by practice of the invention. Additional advantages of the invention will also be realized and attained by means of the elements and combinations particularly pointed out m the appended claims. It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory of certain embodiments of the invention, and are not restrictive of the invention as claimed.
BRIEF DESCRIPTION OF DRAWINGS
Figure 1A illustrates a cross sectional view of an assay device containing one embodiment of a cast analyte diffusion limiting membrane according to the present invention.
Figure IB illustrates a front view of an assay device containing one embodiment of a cast analyte diffusion limiting membrane according to the present invention.
Figure 2 is a graph indicating the results of example 1.
Figure 3 is a graph indicating the results of example 2.
DETAILED DESCRIPTION OF THE INVENTION
The present invention may be understood more readily by reference to the following figures and their previous and following description, including the detailed description of the invention and any examples provided herein. It is to be understood that this invention is not limited to the specific embodiments and methods described, as specific components and/or conditions may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting in any way. It must also be noted that, as used in the specification and the appended claims, the singular forms "a," "an," and "the" comprise plural referents unless the context clearly dictates otherwise. For example, reference to a component in the singular is intended to comprise a plurality of components.
Ranges may be expressed herein as from "about" or "approximately" one particular value and/or to "about" or "approximately" another particular value. When such a range is expressed, another embodiment comprises from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent "about," it will be understood that the particular value forms another embodiment.
As used herein, "analyte" shall mean the component that is being filtered from a liquid or gas and/or detected and/or measured in a detection device. In situations where an analyte is being filtered from a biological fluid, the analyte can include without limitation, glucose, acetoacetate, ammonia, catecholamines, creatine, creatinine, fructose, galactose, β-hydroxybutyric acid, bilirubin, lactate, lactic acid, amino acids, urea, uric acid, salicylates, pH, magnesium, calcium, lithium, lead, potassium, sodium, chloride, iron, and any other electrolyte, vitamin, protein, nutrient, pharmaceutical compounds, or other such characteristic desired.
As used herein, the term "electrolyte" means a chemical compound that ionizes when dissolved to produce an electrically conductive medium.
As used herein, the term "fluid" means a liquid or a gas.
As used herein, the term "biological fluid" means blood serum, whole blood, interstitial fluid, lymph fluid, spinal fluid, plasma or any combinations of these fluids. "Interstitial fluid" further refers to the clear fluid that occupies the space between the cells in the body. As used herein, the term "biological membrane" means the outer layer of an organism, such as skin or mucous membrane, the structure separating one area of an organism from another, such as a capillary wall, or the outer layer of an organism which separates the organism from its external environment, such as skin, buccal mucosa or other mucous membrane.
As used herein, the term "hydrogel" means a polymeric material that can absorb 20% or more of its weight in water while simultaneously maintaining a distinct three- dimensional structure. More specifically, the hydrogels according to the present invention can be comprised of an aerogel that dries without significant collapse of the macroscopic structure and which absorbs water into macropores without substantial macroscopic swelling or, alternatively, xerogels which absorb water by swelling. It is further envisioned by the present invention that suitable hydrogels can include dry polymers that will swell in aqueous environments. Representative examples of suitable hydrogels for use in the present invention include without limitation 2-hydroxyethyl methacrylate, N,N,-dimethacrylamide, N-vinylpyrrolidine, polyethyleneglycol dimethacrylate, and/or copolymers thereof.
As used herein, the term "cast" means a method of forming a coating over an electrode area. Representative examples can include doctor blading, spraying, and/or dipping.
As used herein, the term "diffusion-limiting hydrogel membrane" means a hydrogel that limits the flow of analytes from one space to another.
As used herein, the term "detection device" means any assay device suitable for measuring a desired characteristic of a fluid on a continual or discrete basis. An example of such device is that disclosed by International Patent Application No. PCT/US00/09393 which application is incorporated herein by this reference in its entirety. As used herein, the term "sensor electrode" means an electrode suitable for detecting the concentration of various ions in an aqueous and/or gaseous environment. Examples of suitable sensor electrodes according to the present invention include without limitation platinumized carbon ink or platinum metal held at a given electrical potential to cause the reduction of an analyte.
Referring to figure 1A, the present invention shows a cross-sectional view of a detection device 10 which operates on a continuous basis. The device 10 contains an inlet port 40 to receive fluid and a chamber 50 in fluid communication with the inlet port 40, and an outlet port 60 in fluid communication with the chamber 50, where the outlet port 60 is designed to allow the discharge of fluid.
The chamber 50 further comprises a first working sensor electrode 12, a second working sensor electrode 14, a reference electrode 16 and a counter electrode 18. A first layer of an analyte responsive enzyme 20, such as glucose oxidase, is applied to at least one of the working sensor electrodes 12 or 14. A second layer comprising a composition comprising a diffusion-limiting hydrogel membrane 30 is applied to at least one of the working sensor electrodes 12 or 14, wherein the first layer is in direct contact with at least one sensor electrode and the second layer is in direct contact with the first layer.
According to several embodiments, the device 10 of the present invention may further comprise an external channel 70, wherein one end of the external channel 70 is in fluid communication with the inlet port 40 and the other end is in fluid communication with at least one liquid and/or gas.
In an alternative embodiment, which is not shown in this figure, the analyte responsive enzyme 20 and the composition comprising a diffusion-limiting hydrogel membrane are mixed together and applied to at least one of the working sensor electrodes 12 or 14 as a mono-layer membrane system. Figure IB is a front view of the detection device 10 and is described the same as figure 1 A above.
In one aspect, the present invention provides a diffusion limiting membrane system for filtering an analyte from a liquid, comprising: a) a first layer comprising an analyte responsive enzyme; and b) a second layer comprising a water-soluble monomer composition, wherein the first layer is in direct contact with one or more sensor electrodes and the second layer is in direct contact with the first layer.
In another aspect of the present invention, there is provided a diffusion-limiting hydrogel membrane system for filtering glucose from fluids comprising a glucose limiting membrane comprising a composition comprising a water soluble monomer, an enzyme, and an initiator, wherein the composition is disposed on one or more sensor electrodes and cured in the presence of sunlight or UV light.
In still another aspect, the present invention further provides a diffusion-limiting hydrogel membrane system for filtering glucose from fluids comprising a composition comprising a water soluble monomer, a cross-linking agent, an enzyme, and an initiator, wherein the composition is disposed on one or more sensor electrodes and cured in the presence of sunlight or UV light.
In another aspect, the present invention further provides a diffusion-limiting hydrogel membrane system comprising: a) a first layer comprising an analyte responsive enzyme; and b) a second layer comprising a water-soluble monomer composition, wherein the first layer is in direct contact with one or more sensor electrodes and the second layer is in direct contact with the first layer.
In yet a further embodiment, the present invention provides a diffusion-limiting hydrogel membrane for filtering an analyte from a fluid, comprising: a) a first layer comprising an analyte responsive enzyme; and b) a second layer comprising a water-soluble monomer composition, wherein the first layer is in direct contact with one or more sensor electrodes and the second layer is in direct contact with the first layer.
Suitable analytes for use with the present invention include without limitation glucose, acetoacetate, ammonia, catecholamines, creatine, creatinine, fructose, galactose, β-hydroxybutyric acid, bilirubin, lactate, lactic acid, amino acids, urea, uric acid, salicylates, pH, magnesium, calcium, lithium, lead, potassium, sodium, chloride, iron, and any other electrolyte, vitamin, protein, nutrient, pharmaceutical compounds, or other such characteristic desired.
Suitable analyte responsive enzymes for use in the diffusion-limiting hydrogel membranes of the present invention will be dependent upon the desired use of the invention. For example, in one embodiment, there is provided a diffusion-limiting hydrogel membrane system for filtering glucose from biological fluids. In this environment, the glucose responsive enzyme is glucose oxidase, which is available from Sigma. However, to this end, any appropriate enzyme recognized for use in detecting glucose could be employed.
In still another embodiment, the analyte responsive enzyme is dissolved in deionized water or phosphate buffered de-ionized water. The phosphate buffer system (PBS) acts to maintain the analyte responsive enzyme at a pH value within the range of normal physiological levels. According to the present invention, the analyte responsive enzyme can be dissolved in an amount of from about Img/mL to about lOOmg/mL. In another embodiment, the enzyme is dissolved in an amount of from about Img/mL to about 50mg/mL. In still a further embodiment of the present invention, the enzyme can be dissolved in an amount of from about Img/mL to about lOmg/mL.
Suitable water soluble monomers for use in the present include 2-hydroxyethyl methacrylate, N,N,-dimethacrylamide, N-vinylpyrrolidine, polyethyleneglycol dimethacrylate, and/or copolymers thereof. According to one embodiment, the water- soluble monomers for use in the inventive membranes are highly water permeable hydrogels, such as 2-hydroxyethyl methacrylate (HEMA).
In one embodiment, the water soluble monomer of the present invention is diluted in an aqueous medium. By diluting the hydrogel membrane in an aqueous medium it enables the membrane system to be cast onto sensitive or delicate substrates that ordinarily cannot tolerate the harshness of organic solvents. In one embodiment, the hydrogel monomers of the present invention can be diluted in the aqueous medium at a range of dilution from about 0.01% to about 50% by volume. In another embodiment, the range of dilution is from about 0.05% to about 10% by volume. In still a further embodiment, the range of dilution is from about 0.1% to about 5% by volume.
In another embodiment, the water soluble monomer of the present invention can further comprise one or more initiators. Any water soluble UV or thermal initiators known in the art can be used with the present invention. Representative examples of suitable initiators for use in the invention include 2,2 dimethoxy-2- phenylacetophenone, Vazo 52®, available from DuPont, and Vazo 64®, also available from DuPont. In one embodiment, the initiator is introduced into the water soluble monomer in an amount of from about 1 to about 10% by weight. In another embodiment, the initiator is introduced into the water soluble monomer in an amount of from about 2 to about 5% by weight.
In one embodiment, the water soluble monomer of the present invention can be cast or cured directly onto an electrode in the presence of sunlight or ultraviolet light without requiring the use of an adhesive or special processing to further protect an enzyme within the system.
In another embodiment, the water soluble monomer composition further comprises water soluble cross-linking agents. In this embodiment, the cross-linking agent can participate in the polymerization of the water soluble monomer and thus facilitate the formation of the desired hydrogel membrane. Examples of suitable cross- linking agents for use in the present invention include without limitation polytheyleneglycol dimethacryalate and/or gluteraldehyde. To this end, any water soluble free radical cross-linking agents can be used in the present invention. The cross-linking agents can be introduced into the water soluble monomer in an amount of from about 1 to about 10% by volume. In another embodiment, the cross-linking agent can be introduced into the water soluble monomer in an amount of from about 2 to about 5% by volume.
In one embodiment, the thickness of the membranes of the present invention is from about 2 to about 50 micrometers. In another embodiment, the thickness of the membrane is from about 2 to about 25 micrometers. In still a further embodiment, the thickness of the membrane is from about 2 to about 20 micrometers.
EXAMPLES
Example 1:
Example 1 relates to a bi-layer diffusion-limiting hydrogel membrane system for filtering glucose from biological fluids. First, solution 1 was prepared, and consisted of 1000 μl of 2-hydroxyethyl methacrylate and 4% by weight of a UV initiator, 2,2 Dimethoxy-2-phenylacetophenone . Then, using a detection device 10 such as the one shown in figure 1 A, a 0.5μl drop of solution 2, comprised of 495μl of a phosphate buffer system (PBS), lOμl of gluteraldehyde, 4 mg of Glucose Oxidase, and 30 mg of bovine serum albumin (BSA), was placed on at least one of the working sensor electrodes 12 or 14. This drop was allowed to dry for 12hrs after which a lμl drop of solution 3, which contained 495 μl of PBS and lOμl of solution 1, was placed on top of the drop on the at least one working sensor electrode 12 or 14. This second drop was exposed to long wave U V radiation for 0.5 hrs, wherein the radiation value was approximately 415nm tc approximately 430nm.
The cured hydrogel membrane was then placed in a solution of de-ionized water and PBS and tested against a series of glucose levels as seen in figure 2. The results for this bi-layer hydrogel membrane system are set forth in said figure 2, wherein it illustrates that the bi-layer diffusion limiting hydrogel membrane system of example 1 was suitable for accurately detecting glucose levels at concentrations of up to approximately 25 to 30mM.
Example 2:
Example 2 relates to a single layer diffusion-limiting hydrogel membrane system for filtering glucose from biological fluids. First, solution 1 was prepared, and consisted of 1000 μl of 2-hydroxyethyl methacrylate and 4% by weight of 2,2 Dimethoxy-2-phenylacetophenone. Then, using a detection device 10 such as the one shown in figure 1A, a 0.5μl drop of solution 2, which contained 495μl of PBS, 4 mg of Glucose Oxidase, and 10 μl of solution 1, was placed on at least of the working sensor electrodes 12 or 14. This 0.5μl drop was exposed to long wave UV radiation for 0.5 hrs, wherein the radiation value was approximately 415nm to approximately 430nm.
The cured membrane was then placed in a solution of de-ionized water and PBS and tested against a series of glucose levels as seen in figure 3. The results for this mono-layer hydrogel membrane system are set forth in said figure 3, wherein it illustrates that the mono-layer diffusion limiting hydrogel membrane system of example 2 was suitable for accurately detecting glucose levels at concentrations of up to approximately lOmM.

Claims

We claim:
1. A diffusion-limiting hydrogel membrane system for filtering an analyte from a liquid, comprising: a) a first layer comprising an analyte responsive enzyme; and b) a second layer comprising a water-soluble monomer composition, wherein the first layer is in direct contact with one or more sensor electrodes and the second layer is in direct contact with the first layer.
2. The membrane system of claim 1, wherein the analyte is glucose.
3. The membrane system of claim 1 , wherein the analyte responsive enzyme is glucose oxidase.
4. The membrane system of claim 1, wherein the enzyme is dissolved in deionized water.
5. The membrane system of claim 1, wherein the water soluble monomer comprises 2-hydroxyethyl methacrylate, N,N-dimefhylacrylamide, N- vinylpyrrolidinone, and polyethyleneglycol dimethacrylate, or co-polymers thereof.
6. The membrane system of claim 1, wherein the water-soluble monomer composition further comprises an initiator and an aqueous medium.
7. The membrane system of claim 1 , wherein the membrane system is cured in the presence of sunlight or UV light.
8. The membrane system of claim 1, wherein the water-soluble monomer composition further comprises a water-soluble cross-linking agent.
9. The membrane system of claim 8, wherein the water soluble cross-linking agent is polyeythyleneglycol dimethacrylate.
10. A diffusion- limiting hydrogel membrane system for filtering glucose from fluids, comprising a glucose limiting membrane comprising a composition comprising a water soluble monomer, an enzyme, and an initiator, wherein the composition is disposed on one or more sensor electrodes and cured in the presence of sunlight or UV light.
11. A diffusion-limiting hydrogel membrane system for filtering glucose from fluids, comprising a composition comprising a water soluble monomer, a cross- linking agent, an enzyme, and an initiator, wherein the composition is disposed on one or more sensor electrodes and cured in the presence of sunlight or UV light.
12. A diffusion-limiting hydrogel membrane system comprising: a) a first layer comprising an analyte responsive enzyme; and b) a second layer comprising a water-soluble monomer composition, wherein the first layer is in direct contact with one or more sensor electrodes and the second layer is in direct contact with the first layer.
13. The membrane system of claim 12, wherein the analyte is selected from the group comprising glucose, acetoacetate, ammonia, catecholamines, creatine, creatinine, fructose, galactose, β-hydroxybutyric acid, bilirubin, lactate, lactic acid, amino acids, urea, uric acid, salicylates, pH, magnesium, calcium, lithium, lead, potassium, sodium, chloride or iron.
4. A diffusion- limiting hydrogel membrane for filtering an analyte from a fluid, comprising: a) a first layer comprising an analyte responsive enzyme; and b) a second layer comprising a water-soluble monomer composition, wherein the first layer is in direct contact with one or more sensor electrodes and the second layer is in direct contact with the first layer.
PCT/US2001/003304 2000-02-01 2001-02-01 Cast analyte diffusion-limiting membranes using photopolymerizable hydrophylic monomers WO2001057241A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP01908778A EP1252509A2 (en) 2000-02-01 2001-02-01 Cast analyte diffusion-limiting membranes using photopolymerizable hydrophylic monomers
JP2001555864A JP2003521248A (en) 2000-02-01 2001-02-01 Analyte diffusion limiting membrane by casting using photopolymerizable hydrophilic monomers
CA002398810A CA2398810A1 (en) 2000-02-01 2001-02-01 Cast analyte diffusion-limiting membranes using photopolymerizable hydrophylic monomers
MXPA02007447A MXPA02007447A (en) 2000-02-01 2001-02-01 CAST ANALYTE DIFFUSIONminus;LIMITING MEMBRANES USING PHOTOPOLYMERIZABLE HYDROPHYLIC MONOMERS.
BR0108042-3A BR0108042A (en) 2000-02-01 2001-02-01 Fused analyte diffusion limiting membranes using light-curing hydrophilic monomers
AU36612/01A AU3661201A (en) 2000-02-01 2001-02-01 Cast analyte diffusion-limiting membranes using photopolymerizable hydrophylic monomers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17971600P 2000-02-01 2000-02-01
US60/179,716 2000-02-01

Publications (2)

Publication Number Publication Date
WO2001057241A2 true WO2001057241A2 (en) 2001-08-09
WO2001057241A3 WO2001057241A3 (en) 2002-04-25

Family

ID=22657678

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/003304 WO2001057241A2 (en) 2000-02-01 2001-02-01 Cast analyte diffusion-limiting membranes using photopolymerizable hydrophylic monomers

Country Status (7)

Country Link
EP (1) EP1252509A2 (en)
JP (1) JP2003521248A (en)
AU (1) AU3661201A (en)
BR (1) BR0108042A (en)
CA (1) CA2398810A1 (en)
MX (1) MXPA02007447A (en)
WO (1) WO2001057241A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1466156A2 (en) * 2001-05-15 2004-10-13 Therasense, Inc. Biosensor membranes composed of polymers containing heterocyclic nitrogens
EP2135064A1 (en) * 2007-03-21 2009-12-23 Universiti Putra Malaysia Amperometric biosensor for histamine determination
WO2015081197A1 (en) * 2013-11-27 2015-06-04 Google Inc. Adjustment of sensor sensitivity by controlling copolymer film thickness through a controlled drying step
WO2015084572A1 (en) * 2013-12-06 2015-06-11 Google Inc. Formulation and storage method to enhance the enzyme and sensor stabilities
US9549697B2 (en) 2004-10-28 2017-01-24 Ascensia Diabetes Care Holdings Ag Hydrogel composition

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5502279B2 (en) * 2004-10-28 2014-05-28 エコー セラピューティクス， インコーポレイテッド System and method for analyte sampling and analysis using hydrogels
US9828620B2 (en) * 2013-06-28 2017-11-28 Verily Life Sciences Llc Porous polymeric formulation prepared using monomer
US20220373500A1 (en) 2019-12-11 2022-11-24 Siemens Healthcare Diagnostics Inc. Photocurable reagent(s) for forming chloride ion-selective sensor(s) and methods of production and use thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5228972A (en) * 1988-05-27 1993-07-20 Daikin Industries, Ltd. Apparatus for measuring concentration of test substance in liquid
DE4426694A1 (en) * 1994-07-28 1996-02-08 Eppendorf Geraetebau Netheler Measurement of concn. of substance in body fluid over long time
WO1998020332A1 (en) * 1996-11-07 1998-05-14 Sensalyse Holdings Limited Biosensor incorporating a surfactant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT397661B (en) * 1992-10-06 1994-06-27 Avl Verbrennungskraft Messtech Outer membrane layer of an enzyme electrode

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5228972A (en) * 1988-05-27 1993-07-20 Daikin Industries, Ltd. Apparatus for measuring concentration of test substance in liquid
DE4426694A1 (en) * 1994-07-28 1996-02-08 Eppendorf Geraetebau Netheler Measurement of concn. of substance in body fluid over long time
WO1998020332A1 (en) * 1996-11-07 1998-05-14 Sensalyse Holdings Limited Biosensor incorporating a surfactant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch, Week 199348, Derwent Publications Ltd., London, GB; Class A89, AN 1993-377863, XP002188455 & AT 397 661 B (AVL VERBRENNUNGSKRAFT MESSTECH) 27 June 1994 *

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9014774B2 (en) 2001-05-15 2015-04-21 Abbott Diabetes Care Inc. Biosensor membranes
US9414778B2 (en) 2001-05-15 2016-08-16 Abbott Diabetes Care Inc. Biosensor membranes
EP1466156A2 (en) * 2001-05-15 2004-10-13 Therasense, Inc. Biosensor membranes composed of polymers containing heterocyclic nitrogens
EP1927602A1 (en) 2001-05-15 2008-06-04 Abbott Diabetes Care, Inc. Biosensor membranes composed of polymers containing heterocyclic nitrogens
EP1466156A4 (en) * 2001-05-15 2006-03-01 Therasense Inc Biosensor membranes composed of polymers containing heterocyclic nitrogens
US7670470B2 (en) 2001-05-15 2010-03-02 Abbott Diabetes Care Inc. Biosensor membranes composed of polymers containing heterocyclic nitrogens
EP2292671A1 (en) 2001-05-15 2011-03-09 Abbott Diabetes Care Inc. Membranes composed of polymers containing heterocyclic nitrogens
US9713443B2 (en) 2001-05-15 2017-07-25 Abbott Diabetes Care Inc. Biosensor membranes
US8380274B2 (en) 2001-05-15 2013-02-19 Abbott Diabetes Care Inc. Biosensor membranes composed of polymers containing heterocyclic nitrogens
US8377271B2 (en) 2001-05-15 2013-02-19 Abbott Diabetes Care Inc. Biosensor membranes composed of polymers containing heterocyclic nitrogens
US8437829B2 (en) 2001-05-15 2013-05-07 Abbott Diabetes Care Inc. Biosensor membranes
US9232916B2 (en) 2001-05-15 2016-01-12 Abbott Diabetes Care Inc. Analyte monitoring devices
AU2002367855B2 (en) * 2001-05-15 2006-11-09 Therasense, Inc. Biosensor membranes composed of polymers containing heterocyclic nitrogens
US8147666B2 (en) 2001-05-15 2012-04-03 Abbott Diabetes Care Inc. Biosensor membranes composed of polymers containing heterocyclic nitrogens
US10647846B2 (en) 2004-10-28 2020-05-12 Ascensia Diabetes Care Holdings Ag Electrochemical sensor system
US9549697B2 (en) 2004-10-28 2017-01-24 Ascensia Diabetes Care Holdings Ag Hydrogel composition
US10655004B2 (en) 2004-10-28 2020-05-19 Ascensia Diabetes Care Holdings Ag Electrochemical sensor system
US10988610B2 (en) 2004-10-28 2021-04-27 Ascensia Diabetes Care Holdings Ag Electrochemical sensor system
US10196512B2 (en) 2004-10-28 2019-02-05 Ascensia Diabetes Care Holdings Ag Method of determining an analyte concentration
US10227485B2 (en) 2004-10-28 2019-03-12 Ascensia Diabetics Care Holdings AG Electrochemical sensor system
EP2135064A1 (en) * 2007-03-21 2009-12-23 Universiti Putra Malaysia Amperometric biosensor for histamine determination
EP2135064A4 (en) * 2007-03-21 2014-09-10 Univ Putra Malaysia Amperometric biosensor for histamine determination
US9763605B2 (en) 2013-11-27 2017-09-19 Verily Life Sciences Llc Adjustment of sensor sensitivity by controlling copolymer film thickness through a controlled drying step
WO2015081197A1 (en) * 2013-11-27 2015-06-04 Google Inc. Adjustment of sensor sensitivity by controlling copolymer film thickness through a controlled drying step
WO2015084572A1 (en) * 2013-12-06 2015-06-11 Google Inc. Formulation and storage method to enhance the enzyme and sensor stabilities

Also Published As

Publication number Publication date
BR0108042A (en) 2002-10-29
JP2003521248A (en) 2003-07-15
WO2001057241A3 (en) 2002-04-25
MXPA02007447A (en) 2004-08-23
EP1252509A2 (en) 2002-10-30
AU3661201A (en) 2001-08-14
CA2398810A1 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
US6858403B2 (en) Polymer matrix containing catalase co-immobilized with analytic enzyme that generates hydrogen peroxide
US7351770B2 (en) Ionic hydrophilic high molecular weight redox polymers for use in enzymatic electrochemical-based sensors
CN101971012B (en) Formation of immobilized biological layers for sensing
EP1288654B1 (en) Biosensor
EP1482307B1 (en) Biosensor
JP5640110B2 (en) Composition for forming an immobilized biolayer for sensing
US4240889A (en) Enzyme electrode provided with immobilized enzyme membrane
Hämmerle et al. Amperometric polypyrrole enzyme electrodes: effect of permeability and enzyme location
JP5236824B2 (en) Stabilization of enzyme activity with electrochemical biosensors
EP1304566A1 (en) Biosensor
Mascini et al. Amperometric acetylcholine and choline sensors with immobilized enzymes
AU4216900A (en) Assay device for measuring characteristics of a fluid on a continual basis
JPH0679003B2 (en) Enzyme / electrode type medium sensor
EP0944731A1 (en) Enzyme sensor
CN101223284A (en) Enzyme sensor including a water-containing spacer layer
JP2003510570A (en) Small biosensor for continuous analyte monitoring
Yuan et al. Eliminating the interference of ascorbic acid and uric acid to the amperometric glucose biosensor by cation exchangers membrane and size exclusion membrane
WO2001057241A2 (en) Cast analyte diffusion-limiting membranes using photopolymerizable hydrophylic monomers
US20070215465A1 (en) Biosensor membrane and methods related thereto
US20030052003A1 (en) Cast analyte diffusion-limiting membranes using photopolymerizable hydrophylic monomers
CN214622434U (en) Electrochemical biosensor
TW201407159A (en) Enzymatic electrochemical-based sensors with NAD polymeric coenzyme
Wollenberger et al. Biosensors for analytical microsystems
JP4000322B2 (en) Castable diffusion membranes for use in enzyme-based sensors
Doretti et al. Covalently immobilized choline oxidase and cholinesterases on a methacrylate copolymer for disposable membrane biosensors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 36612/01

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2001 555864

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/007447

Country of ref document: MX

Ref document number: 2398810

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001908778

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10182767

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001908778

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001908778

Country of ref document: EP